NCT06911476 From Inflammation to Remodelling Towards Personalized Diagnosis in Post-acute Sequelae of COVID-19 Status NOT_YET_RECRUITING Phase N/A
NCT06782412 Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types Status RECRUITING Phase PHASE2/PHASE3
NCT06690970 Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients Status RECRUITING Phase N/A
NCT06640413 A Study to Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination With L19-IL2 as a Treatment of Metastatic FAP-positive Solid Tumors Status RECRUITING Phase PHASE1
NCT06578637 Investigation of β-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous Polyposis Status RECRUITING Phase NA
NCT06557590 18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors Status RECRUITING Phase N/A
NCT06387381 68Ga-PSFA PET Imaging in Patients With PSMA/FAP Positive Disease Status RECRUITING Phase EARLY_PHASE1
NCT06189820 Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases Status RECRUITING Phase PHASE2
NCT05919264 FOG-001 in Locally Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT05873777 68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDG Status RECRUITING Phase NA
NCT05692596 The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05262855 Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma Status COMPLETED Phase PHASE2
NCT03061591 Turmeric Supplementation on Polyp Number and Size in Patients With Familial Adenomatous Polyposis. Status UNKNOWN Phase PHASE2
NCT02175004 Extension Study Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP) Status COMPLETED Phase PHASE3
NCT01737398 Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy Status COMPLETED Phase PHASE2/PHASE3
NCT00510692 Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA Status COMPLETED Phase PHASE2/PHASE3